补充皮质类固醇对淋巴结结核病治疗结果的影响:系统性审查和元分析
Chayanika Biswas1, A S Supriya1, Aravind Gandhi2
1Department of Community Medicine, Grant Government Medical College and Sir JJ Group of Hospitals, Mumbai, Maharashtra, India.
Tropical medicine & international health : TM & IH
|December 12, 2025
概括
作为淋巴结结核病的补充治疗的皮质类固醇并没有显著改善完全解脱或症状缓解. 然而,辅助皮质类固醇显示治疗并发症显著减少,尽管有限的高质量证据.
科学领域:
- 传染性疾病 传染性疾病
- 肺部病理学 肺部病理学
- 免疫学 免疫学 免疫学
背景情况:
- 淋巴结结核病 (LNTB) 是结核病的一个显著的肺外表现.
- 对LNTB的最佳治疗策略,特别是辅助疗法的作用,需要进一步阐明.
- 将皮质类固醇纳入LNTB治疗方案的潜在好处和风险需要进行系统评估.
研究的目的:
- 系统评估辅助皮质类固醇在淋巴结结核病治疗中的有效性和安全性.
- 综合来自随机对照试验 (RCT) 关于在LNTB中使用皮质类固醇的证据.
- 评估额外的皮质类固醇对关键治疗结果的影响,包括解决方案,症状缓解和并发症.
主要方法:
- 在主要数据库 (Cochrane,MEDLINE,Embase,Web of Science) 进行了全面的系统文献搜索,截至2025年10月.
- 三个RCT符合PICOTS标准,比较辅助口服普得尼松与LNTB标准抗结核治疗.
- 用随机效应模型分析数据,用I2和t2评估异质性,用GRADE框架对证据的确定性进行分级.
主要成果:
- 辅助皮质类固醇在6个月内没有显著的益处,不能完全解决 (RR=1.61;非常低质量的证据) 或在2个月后缓解症状 (RR=1.21;低质量的证据).
- 随着辅助皮质类固醇治疗,治疗期间出现并发症的显著减少 (RR=0.23;中等质量的证据).
- 所有纳入的研究都呈现出高偏差风险,这有助于对主要结果的证据确定性较低.
结论:
- 目前支持使用辅助皮质类固醇治疗淋巴结结核病的高质量证据有限.
- 虽然皮质类固醇可以减少并发症,但由于低质量的证据,它们对解决方案和症状缓解的影响仍然不确定.
- 需要进一步进行精心设计的随机对照试验,以确定皮质类固醇在LNTB管理中的作用.
相关概念视频
01:29Pulmonary Tuberculosis I
802
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
802
01:28Pulmonary Tuberculosis V
523
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
523
01:26Pulmonary Tuberculosis IV
468
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
468
01:26COPD: Management Using Bronchodilators and Corticosteroids
700
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
700
01:28Pulmonary Tuberculosis II
1.3K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.3K
01:31Pulmonary Tuberculosis III
890
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
890